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Abstract 
Background: The aim of this study was to evaluate the usefulness of a novel clinical score - 
the InterTAK Diagnostic Score in differentiating Takotsubo syndrome (TTS) from acute 
coronary syndrome (ACS). 
Methods: Medical records of 40 consecutive patients with ACS and 20 patients with TTS 
were managed and retrospectively analyzed at the documented center. Each patient was 
evaluated using the InterTAK Diagnostic Score. To illustrate the diagnostic ability of the 
score, a receiver operating characteristic (ROC) curve was performed. 
Results: Takotsube syndrome patients were more often female compared to the ACS group 
(70% vs. 27.5%, p = 0.002), an emotional trigger was more prevalent among the TTS group 
(65% vs. 7.5%, p < 0.001). The area under the curve (AUC) for the score was 0.885 (95% 
confidence interval [CI] 0.78–0.97). Using a cut-off value of 45 points, the sum of sensitivity 
and specificity was the highest. However, when patients with a score of ≥ 50 were diagnosed 
as TTS, 85% were diagnosed correctly. When patients with score ≤ 31 were diagnosed as 
ACS, 92% were diagnosed correctly. 
Conclusions: The InterTAK Diagnostic Score might help in differentiating TTS from ACSs 
with high sensitivity and specificity. This finding requires further investigation to confirm its 
clinical utility.  
Key words: Takotsubo syndrome, broken heart syndrome, acute coronary syndrome, 
clinical score 
 
 
Introduction 
Takotsubo syndrome (TTS), also known as “broken heart syndrome” or “stress 
cardiomyopathy” is an acute heart failure condition characterized by a temporary wall motion 
abnormality of the left ventricle (LV) (hypokinesia, akinesia or dyskinesia) with no significant 
coronary artery obstruction responsible for ischemia [1–4]. Its clinical presentation is similar 
to acute coronary syndrome (ACS). These two conditions share similar symptoms at 
presentation (chest pain, dyspnea), electrocardiogram (ECG) abnormalities, elevated cardiac 
biomarkers and comparable in-hospital mortality [1, 5–10].  The final differential diagnosis 
requires invasive procedures such as coronary angiography and left ventriculography [2]. The 
International Takotsubo Diagnostic Criteria (InterTAK Diagnostic Criteria) can be found in 
the Expert Consensus Document published in European Heart Journal [1, 2]. Since TTS was 
first reported in Japan in 1980s, it has been increasingly recognized all over the world and 
some investigators suggest that TTS could represent 1–3% of all patients with ACS and 5–6% 
of female presenting with suspected STEMI [6, 11]. According recent data about 90% of TTS 
patients are women and around 80% are older than 50 years [12–16]. Recently, in order to 
differentiate TTS and ACS in the acute stage, before coronary angiography, the InterTAK 
Diagnostic Score was created [17]. It considers 7 clinical parameters and could be easily used 
in the emergency room. Authors of the Score postulate its high sensitivity and specificity. The 
maximum number of points to get is 100. According to the creators, in the population they 
studied (TTS vs. ACS ratio 1:2), obtaining ≥ 50 points allows to diagnose TTS with 95% 
accuracy. In turn to diagnose ACS with the same accuracy, ≤ 31 points should be obtained.  
It is important to emphasize, that the model used by InterTAK Diagnostic Score 
creators, does not reflect the true prevalence of TTS. The predicted probability of TTS 
depends on its prevalence in clinical practice. Thus, in real-life, correction must be made.  
The aim of our study was to evaluate the usefulness of the InterTAK Diagnostic Score 
in differentiating TTS from ACS among patients hospitalized in reference cardiological 
department. 
 
Methods 
We analyzed retrospectively the medical records of 20 consecutive patients with TTS 
and 40 patients with ACS hospitalized in our department between 10 October 2014 and 2 
October 2018. TTS was defined based on modified Mayo Clinic Diagnostic Criteria [5, 11]: 
1) a transient wall motion abnormality in the left ventricle beyond a single epicardial coronary 
artery distribution; 2) the absence of obstructive coronary artery disease or angiographic 
evidence of acute plaque rupture, which can explain the wall motion abnormality; 3) new 
electrocardiographic abnormalities or elevation in cardiac troponin values; and 4) the absence 
of myocarditis. We considered the history of possible emotional or physical trigger. Patients 
with pacemaker rhythm were excluded from the study. Each patient was assigned points 
based on the InterTAK Diagnostic Score, which considers the following criteria: female sex 
(25 points), emotional (24 points) or physical trigger (13 points), absence of ST-segment 
depression (12 points), psychiatric disorders (11 points), neurologic disorders (9 points) and 
QTc prolongation (6 points) (Table 1). As a control group, cohort of patients with ACS, 
including patients with ST-segment elevation myocardial infarction, non-ST-segment 
elevation myocardial infarction, or unstable angina, was selected. ACS was diagnosed follow 
ESC recommendations [18, 19]. Data of patient’s clinical profile were collected. This 
included: demographics, vital signs, cardiovascular risk factors, comorbidities, laboratory 
markers, results of electrocardiography, echocardiography and coronary angiography. High 
sensitive troponin T (hsTnT) was assayed at admission and measured using an automated 
quantitative electrochemiluminescence immunoassay (Roche Elecsys, Mannheim, Germany). 
 
Statistical analysis 
The categorical variables were summarized with the frequency of occurrence in each 
group as well as its percentage. The continuous variables were summarized with mean value 
and standard deviation. The differences between groups were assessed with the Fisher exact 
test for categorical variables and with the Student t-Test for continuous ones. Assessment of 
each variable included in the InterTAK scale was performed with univariate logistic 
regression. Optimal cut-off value for our cohort in the InterTAK scale was selected based on 
analysis of reciver-operator curve (ROC). All tests were two-sided and the differences were 
considered statistically significant if the p-values were < 0.05. No correction was applied for 
multiple statistical testing. All analyses were done in the R language environment (version 
3.5.1). 
 
Results 
Medical records of 20 TTS and 40 ACS consecutive patients were analyzed. Baseline 
characteristics of these two cohorts are shown in Table 2. TTS patients were more often 
female compared to ACS group (70% in TTS vs. 27.5% in ACS, p = 0.002) and the emotional 
trigger was more prevalent in this group (65% vs. 7.5%, p < 0.001). No significant differences 
were found in the frequency of physical trigger. The mean value of heart rate and blood 
pressure at the time of admission were similar in both groups. There were no significant 
differences between TTS and ACS patients in mean serum troponin levels, C-reactive protein 
levels and white blood cell count. The analysis of ECG did not reveal any differences between 
groups. QTc prolongation was observed in only 2 patients with TTS.    
In echo examination no differences were found between the mean value of ejection 
fraction, LV end-diastolic diameter as well as left atrium diameter in the long axis view. 
The incidence of hypertension, diabetes mellitus, hypercholesterolemia, smoking, 
chronic obstructive pulmonary disease, neoplasm were the same in both groups.  
In univariate logistic regression each assessment was performed with  each variable 
included in the InterTAK scale. Assessment of each variable can be seen in Figure 1. 
The area under the curve (AUC) for the score was 0.885 (95% confidence interval [CI] 
0.78–0.97), using a cut off value of 45 points the score  of sensitivity was 75% and specificity 
95% for TTS (Fig. 2). When patients with a score of ≥ 50 were diagnosed as TTS, 85% were 
diagnosed correctly. When patients with score ≤ 31 were diagnosed as ACS, 92% of patients 
were diagnosed correctly. The relation between InterTAK score values and predicted 
probability of TTS in the cohort analyzed is shown in Figure 3. 
 
Discussion 
Takotsubo syndrome patients have morbidity and mortality rates that are comparable 
to those of ACS [5, 20–22]. TTS  has long been considered a benign disorder. However, in 
recent years it has been revealed that TTS can be associated with life threatening 
complications including cardiogenic shock and ventricular arrhythmias [2, 23]. Gili et al. [24] 
analyzed data from 2,098 TTS patients. Cardiac arrest occurred in 5.9% of them. Although 
TTS was first described more than 30 years ago, there are still no simple clinical criteria to 
allow distinguishing TTS from ACS. The most common TTS symptoms are acute chest pain, 
dyspnea and syncope. Moreover, new ECG changes, elevation of cardiac biomarkers and LV 
wall motion abnormalities can be observed. Therefore, initially it is difficult to differentiate 
TTS patients from ACS patients. The first diagnostic criteria for TTS was introduced in 2003 
by Abe et al. [25]. Since then, many documents struggling to address this issue have been 
created. One of the latest is the InterTAK Diagnostic Score, developed by investigators from 
Switzerland [17]. The InterTAK Diagnostic Score is comprised of seven clinical parameters 
that can be easily obtained in an emergency department and do not require an imaging 
modality. This Score found its place in the algorithm for TTS in the International Expert 
Consensus Document on Takotsubo Syndrome from 2018. According to an expert committee, 
the InterTAK Diagnostic Score should be considered in symptomatic patients with no ST-
segment elevation [1, 2]. In the present study, the usefulness of the InterTAK Diagnostic 
Score in differentiating TTS from ACS was evaluated among patients hospitalized in the 
Medical University of Warsaw Clinic in Poland. The score boasts high sensitivity and 
specificity — these results seem to confirm this thesis. In clinical practice, TTS is not a 
common condition. The study group size was limited and, due to this fact, calculations were 
hence affected. TTS mainly affects women in post-menopausal age. Women older than 55 
years have an almost 5-fold increase in risk of developing TTS compared to those younger 
than 55 years [13, 14]. In the current study, 70% of TTS patients were women with a mean 
age of 72.4 ± 12.99 years. Psychological triggers represent a range of traumatic emotions 
[20]. However, emotional triggers are not always negative, as positive emotional events can 
also provoke TTS. This entity has been described as the “happy heart syndrome” [26]. In the 
present TTS patients, all psychological triggers were negative and were present in 65% of the 
group. This however, did not achieve statistical significance for most of the parameters 
analyzed, but for the female sex and emotional triggers the p-value was < 0.05. These are the 
two criteria which gained the most points scored in the InterTAK Diagnostic Score.   
The AUC for the score was 0.885, which confirms good accuracy of the test. For a 
cut-off value of 45 points the sum of sensitivity and specificity of the test for the group 
analyzed was the highest, which is close to the result obtained by investigators from Zurich: 
AUC = 0.971 (95% CI 0.96–0.98) in a derivation cohort and AUC = 0.901 (95% CI 0.87–
0.93) in an independent validation cohort [17]. It is worth mentioning that, when using the 
InterTAK Score in clinical practice, the real prevalence of TTS must be considered. The 
current study was based on the model of the one presented by Swiss investigators, and does 
not reflect a true prevalence of TTS. According to the authors, correction for this bias 
revealed that a given score value relates to a lower corresponding probability of TTS, but still 
holds a very strong association of high values with the diagnosis of TTS [17]. According to 
the International Expert Consensus from 2018, the value of 70 score points or more in clinical 
practice indicates a high probability for the presence of TTS [2]. Patients with low probability 
should undergo coronary angiography, while in patients with high score transthoracic 
echocardiography should be considered.  
 
Limitations of the study  
Some of the study limitations were mentioned in the discussion above. First, this study 
reported a single-center experience. Second, the present study involved retrospective data for 
score validation. It is obvious that a prospective approach would be more promising. 
Moreover, the prevalence of TTS in patients admitted to the documented department was low, 
which affected the sample size. This may explain the lack of statistical significance for some 
of the parameters analyzed which are included in the InterTAK score and limit 
generalizability of the present data.  
 
Conclusions 
The InterTAK Diagnostic Score might help differentiating TTS from ACSs with high 
sensitivity and specificity and could be a useful tool for clinicians in the initial decision-
making process This finding requires further investigation to confirm its clinical utility. 
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Table 1. InterTAK Diagnostic Score. 
Criteria Points 
1. Female sex 25 
2. Emotional trigger 24 
3. Physical trigger 13 
4. Absence of ST-segment depression 12 
5. Psychiatric disorders 11 
6. Neurologic disorders 9 
7. QTc prolongation 6 
 
Table 2. Baseline Takotsubo syndrome (TTS) and acute coronary syndrome (ACS) patient 
characteristics. 
Parameter TTS, n = 20 (100%) ACS, n = 40 (100%) P 
Female sex 14 (70%) 11 (27.5%) 0.002 
Age [years] 72.4 ± 12.99 72.9 ± 14.31  0.893 
Triggering factors and symptoms of admission: 
Emotional trigger 13 (65%) 3 (7.5%) 0.000 
Physical trigger 7 (35%) 9 (22.5%) 0.360 
Chest pain 11 (55%) 22 (55%) 1.000 
Dyspnea 6 (30%) 14 (35%) 0.777 
Vital signs 
Heart rate [bpm] 79.76 ± 18.91 77.12 ± 19.20 0.635 
Systolic BP [mmHg] 131.80 ± 22.06 129.85 ± 24.05 0.778 
Diastolic BP [mmHg] 69.87 ± 9.43 72.53 ± 13.39 0.415 
Laboratory tests: 
hs-TnT [ng/mL] 0.21 (0.090–0.460) 0.15 (0.070–0.427) 0.500 
C-reactive protein [mg/L] 23.38 (4.28–57.20) 7.48 (1.91–42.95) 0.546 
WBC [103/µL] 9.12 (7.25–11.25) 9.35 (7.03–11.19) 0.753 
ECG on admission: 
Sinus rhythm 18 (90%) 33 (82.5%) 0.704 
Atrial fibrillation 2 (10%) 6 (15%) 0.707 
ST elevation 3 (15%) 15 (37.5%) 0.084 
ST depression 3 (15%) 8 (20%) 0.736 
Left bundle branch block 1 (5%) 1 (5%) 1.000 
QTc prolongation* 2 (10%) 0 (0%) 0.999 
TTE parameters: 
Ejection fraction [%] 40.9 ± 11.32 46.52 ± 12.52 0.087  
LVDd [mm] 43.5 ± 6.79 46.37 ± 6.06 0.122  
LA [mm] 36.05 ± 5.45 37.87 ± 5.30 0.230 
Types of TTS: 
Apical type 15 (75%)   
Midventricular type 5 (25%)   
Basal type 0   
Focal type 0   
Type of ACS: 
STEMI  13 (32.5%)  
NSTEMI  26 (65%)  
Unstable angina  1 (2.5%)  
Co-morbidities: 
Hypertension 11 (55%)  30 (75%)  0.146  
Diabetes mellitus 4 (20%)  16 (40%) 0.154  
Hypercholesterolemia 10 (50%) 23 (57.5%) 0.596  
COPD or asthma 1 (5%)  6 (15%) 0.407  
Smoking 4 (20%) 18 (45%) 0.088 
Cancer 4 (20%) 3 (7.5%) 0.208 
Neurologic disorders 1 (5%) 7 (17.5%) 0.249 
Psychiatric disorders 4 (20%) 7 (17.5%) 1.000 
Data are shown as number (percentage), mean ± standard deviation or median (interquartile 
range). *QTc ≥440 ms and ≥460 ms for male and female sex, respectively. BP — blood 
pressure; COPD — chronic obstructive pulmonary disease; ECG — electrocardiogram; hs-
TnT — high sensitive troponin T; LA — left atrium diameter; LVDd — left ventricular end-
diastolic dimension; NSTEMI — non-ST-segment elevation myocardial infarction; QTc — 
QT interval corrected for heart rate; STEMI — ST-segment elevation myocardial infarction; 
TTE — transthoracic echocardiogram; WBC — white blood cell count. 
 
Figure 1. Clinical predictors for the diagnosis of Takotsubo syndrome — variables included 
in the InterTAK scale. Univariate logistic regression analysis; CI — confidence interval; OR 
— odds ratio.  
  
 
 
Figure 2. Receiver operating characteristic curve demonstrating area under curve and cut-off 
point. 
Figure 3. Relation between InterTAK score values and predicted probability of Takotsubo 
syndrome in derivation cohort in the Department of Internal Medicine and Cardiology 
Medical University of Warsaw.  
 
 
